N-(3-Hydroxy-2-Methoxypropyl)-hexadecanaMide
|
- $165 - $2200
- Product name: N-(3-Hydroxy-2-Methoxypropyl)-hexadecanaMide
- CAS: 112988-96-2
- MF: C20H41NO3
- MW: 343.54
- EINECS:
- MDL Number:MFCD27978003
- Synonyms:N-(3-Hydroxy-2-Methoxypropyl)-hexadecanaMide;(±)-N-(3-Hydroxy-2-Methoxypropyl)-hexadecanaMide;Hexadecanamide, N-(3-hydroxy-2-methoxypropyl)-
4 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Medical Isotopes, Inc.
- TRC
Package
- 5MG
- 50mg
- 500mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberLIP0004980
- Product description(+/-)-N-(3-HYDROXY-2-METHOXYPROPYL)-HEXADECANAMIDE 95.00%
- Packaging5MG
- Price$502.99
- Updated2021-12-16
- Buy
- ManufacturerMedical Isotopes, Inc.
- Product number65388
- Product description(+/-)-N-(3-Hydroxy-2-methoxypropyl)-hexadecanamide
- Packaging500mg
- Price$2200
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberH946210
- Product description(±)-N-(3-Hydroxy-2-methoxypropyl)-hexadecanamide
- Packaging50mg
- Price$165
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberH946210
- Product description(±)-N-(3-Hydroxy-2-methoxypropyl)-hexadecanamide
- Packaging500mg
- Price$1320
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | LIP0004980 | (+/-)-N-(3-HYDROXY-2-METHOXYPROPYL)-HEXADECANAMIDE 95.00% | 5MG | $502.99 | 2021-12-16 | Buy |
| Medical Isotopes, Inc. | 65388 | (+/-)-N-(3-Hydroxy-2-methoxypropyl)-hexadecanamide | 500mg | $2200 | 2021-12-16 | Buy |
| TRC | H946210 | (±)-N-(3-Hydroxy-2-methoxypropyl)-hexadecanamide | 50mg | $165 | 2021-12-16 | Buy |
| TRC | H946210 | (±)-N-(3-Hydroxy-2-methoxypropyl)-hexadecanamide | 500mg | $1320 | 2021-12-16 | Buy |
Properties
solubility :Methanol
form :Solid
color :White
form :Solid
color :White
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|